Autocrine Motility Factor Receptor and Gastric Cancer Progression
Author Information
Author(s): Y Hironol, S Fushidal, Y Yonemural, H Yamamoto, H Watanabe, A Raz
Primary Institution: Kanazawa University, Gunma University, Wayne State University
Hypothesis
The expression of autocrine motility factor receptor (AMF-R) is associated with disease progression in gastric cancer.
Conclusion
The study found that higher levels of AMF-R expression are linked to poorer prognosis in gastric cancer patients.
Supporting Evidence
- 56.6% of patients showed positive gp78 expression.
- Positive gp78 expression was significantly associated with poor prognosis.
- Patients with gp78 expression had a 5-year survival rate of 37.5% compared to 63.8% for those without.
Takeaway
This study shows that a specific protein in stomach cancer cells can help doctors predict how bad the cancer might get.
Methodology
The study used immunohistochemical staining to evaluate AMF-R expression in 221 gastric cancer specimens and analyzed its correlation with clinical outcomes.
Participant Demographics
139 men and 82 women, ages 28 to 88 years, with various stages of gastric cancer.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website